No Data
Express News | Tiziana Life Sciences Ltd: To Dose First Patient With Moderate Alzheimer's Disease With Foralumab
Express News | Tiziana Life Sciences: FDA Has Allowed Intranasal Foralumab to Be Used Under Expanded Access Ind in First Patient With Moderate Alzheimer S Disease
Tiziana Life Sciences to Dose First Patient With Moderate Alzheimer's Disease With Foralumab
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug
Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; Nvidia to Decline, Micron Technology to Open Higher
The most-talked-about stocks in the Reddit subforum Wallstreetbets were mixed hours before Monday's opening bell. Nvidia (NVDA) fell by 2.4% in premarket hours, declining further after closing Friday
12 Health Care Stocks Moving In Monday's After-Market Session
GainersASLAN Pharma (NASDAQ:ASLN) shares moved upwards by 11.9% to $0.4 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million. Biora Therapeutics (NASDA
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises